About Orthobiologics
Orthobiologics are made with substances found naturally in the human body and are used for treating orthopaedic diseases. They are used for swift healing, faster recovery, and fewer hospital visits.

The analysts forecast the global orthobiologics market to grow at a CAGR of 7.01% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global orthobiologics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the use of bone graft substitutes, visco supplementation, and stem cells across application segments including spinal fusion, reconstructive surgery, and trauma repair.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Orthobiologics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Arthrex
• Bioventus
• Johnson & Johnson Services
• Medtronic
• Stryker

Market driver
• Increase in focus to reduce orthopaedic surgeries
• For a full, detailed list, view our report

Market challenge
• Concerns associated with the use of orthobiologics
• For a full, detailed list, view our report

Market trend
• Emerging technological innovations
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.